Objective To explore the effect of pulmonary surfactant (PS) combined with mechanical ventilation on pulmonary hyaline membrane disease of newborn (HMD) in newborn.

目的探讨肺表面活性物质（PS）与机械通气联用治疗新生儿肺透明膜病（HMD）的疗效及临床价值。

Objectives To study the expression of surfactant protein B(SP-B)and thyroid transcription factor 1(TTF-1)and evaluate the role in neonatal hyaline membrane disease(NHMD).

目的探讨表面活性蛋白B（SP-B）与甲状腺转录因子（TTF-1）在新生儿肺透明膜病中的表达及其意义。

In this paper, we observed the pathological manifestation of all kinds of disease and made an inquiry into the reason and prevention of hereditary malformation and hyaline membrane disease of newborn.

本文对各种疾病的病理表现进行了观察，并对新生儿肺透明膜病及先天畸形的原因及其预防进行了讨论。

Objective:To investigate the therapeutic effect of large dose Ambroxol Hydrochloride combining variant flow rate continuous positive airway by nasal mask to hyaline membrane disease of newborn(HMD).

目的观察大剂量盐酸氨溴索联合可变流量鼻罩持续气道正压通气治疗新生儿肺透明膜病（HMD）的效果。

OBJECTIVE To investigate the way to increase the survival from the hyaline membrane disease.

目的探讨提高新生儿肺透明膜病生存率的方法。

Neonatal pulmonary hyaline membrane disease is a serious disease in the early newborn.

新生儿肺透明膜病是新生儿早期的严重疾病。

Objective: To improve recognition of imaging diagnosis for hyaline membrane disease (HMD) in neonatal.

目的：探讨新生儿肺透明膜病（HMD）的影像表现特征。

Objective: To explore the application and nursing of nasal-obstruction continuous positive airway pressure (NCPAP) in the prevention and treatment of hyaline membrane disease of newborns.

目的：探讨鼻塞法持续呼吸道正压通气（NCPAP）在防治新生儿肺透明膜病的应用及护理。

Conclusion (1)The incidence of wet lung of newborn and hyaline membrane disease will be increased in neonates delivered by elective caesarean section.

结论（1）选择性剖宫产新生儿湿肺、肺透明膜病等的发生率上升。

Objective:To explore the effect of mechanical ventilation (MV) on premature infants with hyaline membrane disease (HMD )and its problems.

目的探讨分析应用机械通气治疗早产儿肺透明膜病（HMD）近期效果及存在的问题。

Objective: To discuss the clinical value of pulmonary surfactant (PS) in the replacement therapy for premature infants with hyaline membrane disease (HMD).

目的：探讨肺表面活性物质（PS）治疗早产儿肺透明膜病（HMD）的疗效及临床价值。

Objective To analyze the effect of breathing support of nasal continuous positive airway pressure(NCPAP)in hyaline membrane disease (HMD) of the newborn.

目的探讨鼻塞式持续气道正压通气 （NCPAP）在新生儿肺透明膜病中的呼吸支持作用及其护理。

Methods:Bedside chest CR films from 120 newborns with pulmonary hyaline membrane disease were retrospectively analyzed according to X-ray diagnostic and grading criteria.

方法：按照X线诊断和分级标准，对临床确诊的120例新生儿肺透明膜病病例的床旁胸部CR片进行回顾性分析。

The distribution of the lesions, evolvement of disease and whether airbronchgram or not are different between hyaline membrane disease and pneumonia in the newborn patients.

在新生儿组的常见两种疾病肺透明膜病和新生儿肺炎中，两者在病变的分布范围、有无支气管气像及治疗后病变演变方面具有差异。

CONCLUSIONS Good curing, nursing care and quality control for nosocomial infection will increase the survival from the hyaline membrane disease.

结论合适的治疗方法、有效的护理措施和医院感染控制可提高患儿的生存率。

Conclusion:The bedside chest CR is a useful imaging tool for the diagnosis of newborns with pulmonary hyaline membrane disease, and it is the main method to understand the disease cause and treatment.

结论：床旁CR胸片对肺透明膜病的诊断具有很高的价值，是及时了解病程发展与治疗效果的主要手段。

2 hyaline membrane disease in newborn children merger eventually two cases death.

2例患儿合并新生儿透明膜病，最终死亡。

In the follow-up radiographies, the hyaline membrane disease need follow up during 1 to 3 days but the pneumonia need follow up during 3 to 5days.

在治疗过程追踪复查中，肺透明膜病需要1至3天内短期复查；新生儿肺炎一般在3至5天内复查。

Conclusion Pulmonary surfactant therapy in hyaline membrane disease of newborns can quickly correct the abnormal blood gas, and hence is worthy of being recommended in clinical practice.

结论肺表面活性物质治疗肺透明膜病，可以迅速纠正患者的血气指标异常，值得临床推广应用。

Preterm hyaline membrane disease;

肺透明膜病；